Efficacy of Conversion From Bedtime NPH Insulin Injection to Once- or Twice-Daily Injections of Insulin Glargine in Type 1 Diabetic Patients Using Basal/Bolus Therapy
- 1 February 2004
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (2), 632-633
- https://doi.org/10.2337/diacare.27.2.632
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.Diabetes Care, 2000
- Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.Diabetes Care, 2000
- Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes.Diabetes Care, 2000